DavidMichaelMintzerMD

PubMed

• But Where is My Doctor? The Increasing and Relentless Fragmentation of Oncology Care.
  David M Mintzer> ;Journal of Clinical Oncology. 2023 Sep 10
• Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance).
  Teresa L. Deshields, Amylou C. Dueck, Kerry A. Rogers, Jennifer R. Brown, Tait D. Shanafelt, David Mintzer, John C. Byrd> ;Leukemia & Lymphoma. 2019 Mar 27
• 19 citations
  Risk Factors Associated with Unplanned Hospital Readmissions in Adults with Cancer.
  Clara Granda-Cameron, Maryam Behta, Mary Hovinga, Al Rundio, David M. Mintzer> ;Oncology Nursing Forum. 2015 May 1
• 15 citations
  BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia
  Philipp W. Raess, David M. Mintzer, Michael A. Husson, Megan O. Nakashima, Jennifer J.D. Morrissette, Robert Daber, Adam Bagg> ;Blood. 2013 Oct 24
• Oncodoxes.
  David M Mintzer> ;Journal of Clinical Oncology. 2013 Jan 20
• 22 citations
  Phase II Multicenter Trial of Albumin-Bound Paclitaxel and Capecitabine in First-Line Treatment of Patients With Metastatic Breast Cancer
  Lee S. Schwartzberg, Francis P. Arena, David M. Mintzer, Amanda L. Epperson, Mark S. Walker> ;Clinical Breast Cancer. 2012 Apr 1
• 21 citations
  A Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab with or Without Bevacizumab as Frontline Therapy for Metastatic Colorectal Cancer. A Fox Chase Extramural ...
  Efrat Dotan, Neal J. Meropol, Barbara Burtness, Crystal S. Denlinger, James C. Lee, David M. Mintzer, Fang Zhu, Karen Ruth, Holly Tuttle, Judi Sylvester, Steven J. Cohen> ;Journal of Gastrointestinal Cancer. 2012 Feb 1
• Phase II study of bevacizumab and erlotinib in treatment-naive elderly patients (older than age 65) with advanced non-small cell lung cancer (NSCLC).
  Borghaei H, Mehra R, Millenson MM, Tuttle H, Ruth K, Magdalinski AJ, Mintzer DM, Lee J, Stevenson J, Langer CJ> ;J. Clin. Oncol.. 2011-05-20
• 31 citations
  An interdisciplinary approach to manage cancer cachexia.
  Clara Granda-Cameron, Debra DeMille, Mary Pat Lynch, Christine Huntzinger, Theresa Alcorn, Joan Levicoff, Carly Roop, David M. Mintzer> ;Clinical Journal of Oncology Nursing. 2010 Jan 29
• 16 citations
  Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania H...
  David M. Mintzer, Sarah Zheng, Michiko Nagamine, Jason G. Newman, Maria Benito> ;The Oncologist. 2010 Jan 1
• 67 citations
  Drug-induced hematologic syndromes.
  David M. Mintzer, Shira N. Billet, Lauren Chmielewski> ;Advances in Hematology. 2009 Jul 7
• Cardiac safety of docetaxel/cyclophosphamide/trastuzumab (DCH) as adjuvant therapy for HER-2 (+) early stage breast cancer.
  Mato A, Cappa M, Fox K, Policarpo G, Cohen J, Wall H, Rossi S, Mintzer D> ;J. Clin. Oncol.. 2009-05-20
• Toward the elimination of medical oncology admissions.
  Mintzer DM, Zheng S, Sprandio J> ;J. Clin. Oncol.. 2009-05-20
• 38 citations
  Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017.
  Hossein Borghaei, Corey J. Langer, Michael Millenson, Karen Ruth, Samuel Litwin, Holly Tuttle, Judie Sylvester Seldomridge, Marc Rovito, David M. Mintzer, Roger B. Coh...> ;Journal of Thoracic Oncology. 2008 Nov 1
• 6 citations
  Promising Survival in Patients with Recurrent Non-small Cell Lung Cancer Treated with Docetaxel and Gemcitabine in Combination as Second-Line Therapy
  Chao Hui Huang, Michael Millenson, Eric J. Sherman, Hossein Borghaei, David M. Mintzer, Roger B. Cohen, Arthur P. Staddon, Judi Seldomridge, Ocn Joseph Treat, Holly Tu...> ;Journal of Thoracic Oncology. 2008 Sep 1
• Phase II trial of cetuximab (C225) in combination with monthly carboplatin (Cb) and weekly paclitaxel (Pac) in patients with advanced NSCLC: Promising early results.
  Borghaei H, Langer CJ, Millenson M, Tuttle H, Seldomridge J, Rovito M, Mintzer D, Treat J> ;J. Clin. Oncol.. 2008-05-20
• Bringing an inpatient palliative care program to a teaching hospital: lessons in leadership.
  Clara Granda-Cameron, Mary Pat Lynch, David M. Mintzer, Dorothy Counts, Shailish Pinto, Margaret Crowley> ;Oncology Nursing Forum. 2007 Aug 27
• 4 citations
  Treating one of our own.
  Kim E. Consalvo, Linda D. Piscitelli, Lindsay Williamson, Gina D. Policarpo, Marianne Englander, Kara Lyons, Cynthia Wise, Tracy Manuella, David M. Mintzer, Mary Pat L...> ;Clinical Journal of Oncology Nursing. 2007 Jun 15
• 22 citations
  On How Increasing Numbers of Newer Cancer Therapies Further Delay Referral to Hospice: The Increasing Palliative Care Imperative
  David M. Mintzer, Kathryn Zagrabbe> ;The American Journal of Hospice & Palliative Care. 2007 Apr 1
• 21 citations
  Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program.
  Coleman K. Obasaju, Z. Ye, Antoinette J. Wozniak, Chandra P. Belani, Mary Louise Keohan, Helen J. Ross, Jonathan Polikoff, David M. Mintzer, Matthew J. Monberg, Pasi A...> ;Lung Cancer. 2007 Feb 1
• 51 citations
  Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program
  Pasi A. Jänne, Antoinette J. Wozniak, Chandra P. Belani, Mary Louise Keohan, Helen J. Ross, Jonathan Polikoff, David M. Mintzer, Z. Ye, Matthew J. Monberg, Coleman K. ...> ;Journal of Thoracic Oncology. 2006 Jul 1
• 19 citations
  Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: A phase II trial
  Joseph Treat, Philip Bonomi, Michael McCleod, Neal P. Christiansen, David M. Mintzer, Matthew J. Monberg, Z. Ye, Ruqin Chen, Coleman K. Obasaju> ;Lung Cancer. 2006 Jul 1
• Phase II trial of nanoparticle albumin-bound paclitaxel (ABX) + capecitabine (XEL) in first line treatment of metastatic breast cancer (MBC).
  Mintzer D, Schwartzberg LS, Cobb P, Henry D, Epperson A, Fortner BV> ;J. Clin. Oncol.. 2006-06-20
• 43 citations
  Chemotherapy-Induced Amenorrhea from Adjuvant Breast Cancer Treatment: The Effect of the Addition of Taxanes
  Amy L. Davis, Matthew Klitus, David M. Mintzer> ;Clinical Breast Cancer. 2005 Dec 1
• On the deluge of unsubscribed medical oncology information.
  David M. Mintzer, Lauren Chmielewski> ;Journal of Clinical Oncology. 2005 Jul 20
• Join now to see all